Dianthus Therapeutics Inc (DNTH)

Aug 21, 2026

Bank of America Corp DE Trims Stake in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 21, 2026

Aug 20, 2026

Royal Bank of Canada Has $1.60 Million Stock Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 20, 2026

Aug 20, 2026

Eagle Health Investments LP Takes Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 20, 2026

Aug 20, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Sets New 52-Week HighStill a Buy? - MarketBeat

Aug 20, 2026

Aug 19, 2026

Simon Read Sells 2,778 Shares of Dianthus Therapeutics (NASDAQ:DNTH) Stock - MarketBeat

Aug 19, 2026

Aug 19, 2026

Dianthus Therapeutics director Simon Read sells $326,553 in stock By Investing.com - Investing.com Australia

Aug 19, 2026

Aug 19, 2026

Dianthus Therapeutics director Simon Read sells $326,553 in stock - Investing.com

Aug 19, 2026

Aug 19, 2026

Dianthus (DNTH) Stock: Ends Down by 2.20% at $113.00 at the Close; Market Levels: the Supplied Trading Band Runs From $107.35 to $118.65 at the ClosePre-Earnings Momentum - Vinanet

Aug 19, 2026

Aug 19, 2026

Handelsbanken Fonder AB Invests $1.49 Million in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 19, 2026

Aug 19, 2026

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Aug 19, 2026

Aug 18, 2026

DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results - Stocktwits

Aug 18, 2026

Aug 18, 2026

TimesSquare Capital Management LLC Acquires Shares of 166,357 Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 18, 2026

Aug 17, 2026

SCS Capital Management LLC Takes Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 17, 2026

Aug 15, 2026

Walleye Capital LLC Takes Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 15, 2026

Aug 14, 2026

Dianthus Therapeutics SVP Adam M. Veness Exercises 15,000 Stock Options at $18.17 Each - Kalkine Media

Aug 14, 2026

Aug 14, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week HighTime to Buy? - MarketBeat

Aug 14, 2026

Aug 14, 2026

Dianthus Therapeutics stock hits 52-week high at 114.64 USD By Investing.com - Investing.com Nigeria

Aug 14, 2026

Aug 14, 2026

Dianthus Therapeutics stock hits 52-week high at 114.64 USD - Investing.com

Aug 14, 2026

Aug 14, 2026

Sirenia Capital reveals 1.70M-share DNTH stake in Dianthus Therapeutics (DNTH) - Stock Titan

Aug 14, 2026

Aug 13, 2026

Dianthus Therapeutics (DNTH): Wellington group discloses 3.23M-share, 5.9% passive stake - Stock Titan

Aug 13, 2026

Aug 12, 2026

Dianthus therapeutics director Simon Read sells $304k in stock By Investing.com - Investing.com South Africa

Aug 12, 2026

Aug 12, 2026

Dianthus Therapeutics SVP Adam Veness sells $2.2m common stock By Investing.com - Investing.com Nigeria

Aug 12, 2026

Aug 12, 2026

Dianthus therapeutics director Simon Read sells $304k in stock - Investing.com

Aug 12, 2026

Aug 12, 2026

Dianthus Therapeutics SVP Adam Veness sells $2.2m common stock - Investing.com

Aug 12, 2026

Aug 11, 2026

Anne Mcgeorge Sells 7,750 Shares of Dianthus Therapeutics (NASDAQ:DNTH) Stock - MarketBeat

Aug 11, 2026

Aug 11, 2026

Dianthus Therapeutics (NASDAQ:DNTH) SVP Sells 16,167 Shares of Stock - MarketBeat

Aug 11, 2026

Aug 11, 2026

Dianthus Therapeutics (NASDAQ:DNTH) SVP Sells $424,313.10 in Stock - MarketBeat

Aug 11, 2026

Aug 11, 2026

Dianthus Therapeutics Insider Sold Shares Worth $844,822, According to a Recent SEC Filing - marketscreener.com

Aug 11, 2026

Aug 10, 2026

DNTH insider Adam M. Veness plans Rule 144 sale of 16,167 shares - Stock Titan

Aug 10, 2026

Aug 10, 2026

Dianthus Therapeutics, Inc. /DE/ SEC Filing (Aug 10, 2026) - Stock Titan

Aug 10, 2026

Aug 10, 2026

Assenagon Asset Management S.A. Makes New Investment in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 10, 2026

Aug 10, 2026

Evercore Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $134 - Moomoo

Aug 10, 2026

Aug 10, 2026

HC Wainwright Issues Optimistic Outlook for DNTH Earnings - MarketBeat

Aug 10, 2026

Aug 09, 2026

California State Teachers Retirement System Raises Stock Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 09, 2026

Aug 08, 2026

Dianthus Therapeutics CEO Marino Garcia sells $17.9m in shares By Investing.com - Investing.com Australia

Aug 08, 2026

Aug 08, 2026

Dianthus Therapeutics CEO Marino Garcia sells $17.9m in shares - Investing.com

Aug 08, 2026

Aug 07, 2026

Dianthus Therapeutics(DNTH.US) Officer Sells US$17.95 Million in Common Stock - Moomoo

Aug 07, 2026

Aug 07, 2026

Marino Garcia Sells 166,000 Shares of Dianthus Therapeutics (NASDAQ:DNTH) Stock - MarketBeat

Aug 07, 2026

Aug 07, 2026

Dianthus Therapeutics, Inc. /DE/ SEC Filing (Aug 7, 2026) - stocktitan.net

Aug 07, 2026

Aug 07, 2026

Dynathera (DNTH) insider schedules 3,833-share stock sale under Rule 144 - Stock Titan

Aug 07, 2026

Aug 07, 2026

Dnth Holdings (DNTH) plans Rule 144 resale of 126,000 shares via Morgan Stanley - Stock Titan

Aug 07, 2026

Aug 07, 2026

Dianthus Therapeutics (DNTH): T. Rowe Price reports 12.1% ownership stake - Stock Titan

Aug 07, 2026

Aug 07, 2026

Dianthus Therapeutics (DNTH): T. Rowe Price reports 7.1% stake in common stock - Stock Titan

Aug 07, 2026

Aug 07, 2026

Dianthus Therapeutics CEO Marino Garcia reports disposal of 166,000 common shares worth $17.97 million - Bitget

Aug 07, 2026

Aug 07, 2026

Dianthus Therapeutics (DNTH) Stock Analysis: A Promising Biotech with 19.46% Potential Upside - DirectorsTalk Interviews

Aug 07, 2026

Aug 07, 2026

The Manufacturers Life Insurance Company Grows Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Aug 07, 2026

Aug 06, 2026

DIANTHUS THERAPEUTICS INC : RAYMOND JAMES RAISES TARGET PRICE TO $131 FROM $125 - webull.com

Aug 06, 2026

Aug 06, 2026

DIANTHUS THERAPEUTICS INC : WEDBUSH RAISES TARGET PRICE TO $122 FROM $105 - webull.com

Aug 06, 2026